• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

METTL3 介导的 FBXW7 的 mA mRNA 修饰抑制肺腺癌。

METTL3-mediated mA mRNA modification of FBXW7 suppresses lung adenocarcinoma.

机构信息

Department of Respiratory Diseases, Xijing Hospital, Fourth Military Medical University, Chang-Le Xi Street #127, Xi'an, 710032, People's Republic of China.

State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Chang-Le Xi Street #169, Xi'an, 710032, People's Republic of China.

出版信息

J Exp Clin Cancer Res. 2021 Mar 6;40(1):90. doi: 10.1186/s13046-021-01880-3.

DOI:10.1186/s13046-021-01880-3
PMID:33676554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7936500/
Abstract

BACKGROUND

FBXW7 mA modification plays an important role in lung adenocarcinoma (LUAD) progression; however, the underlying mechanisms remain unclear.

METHODS

The correlation between FBXW7 and various genes related to mA modification was analyzed using The Cancer Genome Atlas database. The regulatory effects of METTL3 on FBXW7 mRNA mA modification were examined in a cell model, and the underlying mechanism was determined by methylated RNA immunoprecipitation, RNA immunoprecipitation, luciferase reporter, and mutagenesis assays. In vitro experiments were performed to further explore the biological effects of METTL3-mediated FBXW7 mA modification on LUAD development.

RESULTS

Decreased FBXW7 expression was accompanied by downregulated METTL3 expression in human LUAD tissues and was associated with a worse prognosis for LUAD in The Cancer Genome Atlas database. mA was highly enriched in METTL3-mediated FBXW7 transcripts, and increased mA modification in the coding sequence region increased its translation. Functionally, METTL3 overexpression or knockdown affected the apoptosis and proliferation phenotype of LUAD cells by regulating FBXW7 mA modification and expression. Furthermore, FBXW7 overexpression in METTL3-depleted cells partially restored LUAD cell suppression in vitro and in vivo.

CONCLUSIONS

Our findings reveal that METTL3 positively regulates FBXW7 expression and confirm the tumor-suppressive role of mA-modified FBXW7, thus providing insight into its epigenetic regulatory mechanisms in LUAD initiation and development.

摘要

背景

FBXW7 mA 修饰在肺腺癌(LUAD)进展中起着重要作用;然而,其潜在机制尚不清楚。

方法

使用癌症基因组图谱数据库分析 FBXW7 与各种与 mA 修饰相关的基因之间的相关性。在细胞模型中检测 METTL3 对 FBXW7 mRNA mA 修饰的调节作用,并通过甲基化 RNA 免疫沉淀、RNA 免疫沉淀、荧光素酶报告和突变分析确定其潜在机制。进行体外实验以进一步探讨 METTL3 介导的 FBXW7 mA 修饰对 LUAD 发展的生物学影响。

结果

在人类 LUAD 组织中,FBXW7 表达降低伴随着 METTL3 表达降低,并且在癌症基因组图谱数据库中与 LUAD 的预后不良相关。mA 在 METTL3 介导的 FBXW7 转录本中高度富集,并且编码序列区域中 mA 修饰的增加增加了其翻译。功能上,METTL3 的过表达或敲低通过调节 FBXW7 mA 修饰和表达影响 LUAD 细胞的凋亡和增殖表型。此外,在 METTL3 耗尽的细胞中过表达 FBXW7 部分恢复了 LUAD 细胞在体外和体内的抑制作用。

结论

我们的研究结果表明,METTL3 正向调节 FBXW7 的表达,并证实了 mA 修饰的 FBXW7 的肿瘤抑制作用,从而深入了解其在 LUAD 起始和发展中的表观遗传调控机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b4/7936500/9ffcf36c4469/13046_2021_1880_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b4/7936500/78ea0c9715f4/13046_2021_1880_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b4/7936500/298a28ba245f/13046_2021_1880_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b4/7936500/74d454f20a82/13046_2021_1880_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b4/7936500/15191521922f/13046_2021_1880_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b4/7936500/cd40fcef3c40/13046_2021_1880_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b4/7936500/cb367942cadc/13046_2021_1880_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b4/7936500/9ffcf36c4469/13046_2021_1880_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b4/7936500/78ea0c9715f4/13046_2021_1880_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b4/7936500/298a28ba245f/13046_2021_1880_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b4/7936500/74d454f20a82/13046_2021_1880_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b4/7936500/15191521922f/13046_2021_1880_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b4/7936500/cd40fcef3c40/13046_2021_1880_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b4/7936500/cb367942cadc/13046_2021_1880_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54b4/7936500/9ffcf36c4469/13046_2021_1880_Fig7_HTML.jpg

相似文献

1
METTL3-mediated mA mRNA modification of FBXW7 suppresses lung adenocarcinoma.METTL3 介导的 FBXW7 的 mA mRNA 修饰抑制肺腺癌。
J Exp Clin Cancer Res. 2021 Mar 6;40(1):90. doi: 10.1186/s13046-021-01880-3.
2
N-methyladenosine-modified SRPK1 promotes aerobic glycolysis of lung adenocarcinoma via PKM splicing.N6-甲基腺苷修饰的 SRPK1 通过剪接 PKM 促进肺腺癌的有氧糖酵解。
Cell Mol Biol Lett. 2024 Aug 2;29(1):106. doi: 10.1186/s11658-024-00622-5.
3
METTL3 -mediated m6A modification of circ_0000620 regulates cisplatin sensitivity and apoptosis in lung adenocarcinoma via the MiR-216b-5p/KRAS axis.METTL3 介导的 circ_0000620 的 m6A 修饰通过 miR-216b-5p/KRAS 轴调节肺腺癌对顺铂的敏感性和细胞凋亡。
Cell Signal. 2024 Nov;123:111349. doi: 10.1016/j.cellsig.2024.111349. Epub 2024 Aug 15.
4
METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma.METTL3 通过协同作用调控 m6A 甲基化和组蛋白修饰来调节 VGF 在肺腺癌中的功能。
Clin Epigenetics. 2023 Sep 23;15(1):153. doi: 10.1186/s13148-023-01568-9.
5
ARMCX1 inhibits lung adenocarcinoma progression by recruiting FBXW7 for c-Myc degradation.ARMCX1 通过招募 FBXW7 降解 c-Myc 抑制肺腺癌进展。
Biol Direct. 2024 Sep 16;19(1):82. doi: 10.1186/s13062-024-00532-8.
6
The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of .肝脏微环境通过 METTL3 介导的 促进肺腺癌细胞增殖、转移和上皮-间充质转化。
Aging (Albany NY). 2021 Jan 20;13(3):4357-4369. doi: 10.18632/aging.202397.
7
mA mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.METTL3 介导的 mA mRNA 甲基化直接促进 YAP 翻译,并通过调节 MALAT1-miR-1914-3p-YAP 轴增加 YAP 活性,从而诱导 NSCLC 耐药和转移。
J Hematol Oncol. 2019 Dec 9;12(1):135. doi: 10.1186/s13045-019-0830-6.
8
Fbxw7 and Skp2 Regulate Stem Cell Switch between Quiescence and Mitotic Division in Lung Adenocarcinoma.Fbxw7 和 Skp2 调控肺腺癌干细胞在静止期和有丝分裂分裂之间的转换。
Biomed Res Int. 2019 Aug 25;2019:9648269. doi: 10.1155/2019/9648269. eCollection 2019.
9
KIAA1429 Induces m6A Modification of LINC01106 to Enhance the Malignancy of Lung Adenocarcinoma Cells via the JAK/STAT3 Pathway.KIAA1429 通过 JAK/STAT3 通路诱导 LINC01106 的 m6A 修饰来增强肺腺癌细胞的恶性程度。
Crit Rev Immunol. 2024;44(6):49-61. doi: 10.1615/CritRevImmunol.2024052728.
10
The essential roles of mA RNA modification to stimulate ENO1-dependent glycolysis and tumorigenesis in lung adenocarcinoma.m6A RNA 修饰在刺激肺腺癌中 ENO1 依赖性糖酵解和肿瘤发生中的基本作用。
J Exp Clin Cancer Res. 2022 Jan 25;41(1):36. doi: 10.1186/s13046-021-02200-5.

引用本文的文献

1
Targeting METTL3 mitigates venetoclax resistance via proteasome-mediated modulation of MCL1 in acute myeloid leukemia.靶向METTL3通过蛋白酶体介导的急性髓系白血病中MCL1的调节减轻维奈托克耐药性。
Cell Death Dis. 2025 Apr 1;16(1):233. doi: 10.1038/s41419-025-07560-w.
2
STM2457 impairs the proliferation of esophageal squamous cell carcinoma by activating DNA damage response through ATM-Chk2 axis.STM2457通过ATM-Chk2轴激活DNA损伤反应来损害食管鳞状细胞癌的增殖。
Med Oncol. 2025 Feb 22;42(3):82. doi: 10.1007/s12032-025-02634-3.
3
Comprehensive Analysis of m6A-Related Programmed Cell Death Genes Unveils a Novel Prognostic Model for Lung Adenocarcinoma.

本文引用的文献

1
Roles of METTL3 in cancer: mechanisms and therapeutic targeting.METTL3 在癌症中的作用:机制与治疗靶点。
J Hematol Oncol. 2020 Aug 27;13(1):117. doi: 10.1186/s13045-020-00951-w.
2
The 18S rRNA m A methyltransferase METTL5 promotes mouse embryonic stem cell differentiation.18S rRNA mA 甲基转移酶 METTL5 促进小鼠胚胎干细胞分化。
EMBO Rep. 2020 Oct 5;21(10):e49863. doi: 10.15252/embr.201949863. Epub 2020 Aug 11.
3
Mechanism of RNA modification N6-methyladenosine in human cancer.RNA 修饰 N6-甲基腺苷在人类癌症中的作用机制。
m6A相关程序性细胞死亡基因的综合分析揭示了一种新的肺腺癌预后模型。
J Cell Mol Med. 2025 Jan;29(2):e70255. doi: 10.1111/jcmm.70255.
4
The therapeutic potential of RNA m(6)A in lung cancer.RNA m(6)A在肺癌中的治疗潜力。
Cell Commun Signal. 2024 Dec 31;22(1):617. doi: 10.1186/s12964-024-01980-5.
5
m6A methyltransferase METTL3 promotes non-small-cell lung carcinoma progression by inhibiting the RIG-I-MAVS innate immune pathway.m6A甲基转移酶METTL3通过抑制RIG-I-MAVS天然免疫途径促进非小细胞肺癌进展。
Transl Oncol. 2025 Jan;51:102230. doi: 10.1016/j.tranon.2024.102230. Epub 2024 Dec 2.
6
METTL3 affects the biological function of lung adenocarcinoma through the FGF2/PI3K/AKT /mTOR pathway.METTL3通过FGF2/PI3K/AKT/mTOR信号通路影响肺腺癌的生物学功能。
Front Oncol. 2024 Oct 21;14:1474701. doi: 10.3389/fonc.2024.1474701. eCollection 2024.
7
Notch-Driven Cholangiocarcinogenesis Involves the Hippo Pathway Effector TAZ via METTL3-m6A-YTHDF1.Notch驱动的胆管癌发生通过METTL3-m6A-YTHDF1涉及Hippo信号通路效应分子TAZ。
Cell Mol Gastroenterol Hepatol. 2025;19(1):101417. doi: 10.1016/j.jcmgh.2024.101417. Epub 2024 Oct 5.
8
Molecular insights and clinical implications for the tumor suppressor role of SCF E3 ubiquitin ligase.SCF E3 泛素连接酶的肿瘤抑制作用的分子见解和临床意义。
Biochim Biophys Acta Rev Cancer. 2024 Sep;1879(5):189140. doi: 10.1016/j.bbcan.2024.189140. Epub 2024 Jun 21.
9
Association between methyltransferase-like 3 and non-small cell lung cancer: pathogenesis, therapeutic resistance, and clinical applications.甲基转移酶样3与非小细胞肺癌的关联:发病机制、治疗耐药性及临床应用
Transl Lung Cancer Res. 2024 May 31;13(5):1121-1136. doi: 10.21037/tlcr-24-85. Epub 2024 May 24.
10
New link between RNH1 and E2F1: regulates the development of lung adenocarcinoma.RNH1 与 E2F1 之间的新联系:调节肺腺癌的发展。
BMC Cancer. 2024 May 24;24(1):635. doi: 10.1186/s12885-024-12392-6.
Mol Cancer. 2020 Jun 8;19(1):104. doi: 10.1186/s12943-020-01216-3.
4
The potential role of RNA N6-methyladenosine in Cancer progression.RNA N6-甲基腺苷在癌症进展中的潜在作用。
Mol Cancer. 2020 May 12;19(1):88. doi: 10.1186/s12943-020-01204-7.
5
Inactivation of Impairs dsRNA Sensing and Confers Resistance to PD-1 Blockade.失活 可抑制 dsRNA 感应并赋予对 PD-1 阻断的抗性。
Cancer Discov. 2020 Sep;10(9):1296-1311. doi: 10.1158/2159-8290.CD-19-1416. Epub 2020 May 5.
6
mA Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer.mA 修饰在编码和非编码 RNA 中的作用及其在癌症中的治疗意义。
Cancer Cell. 2020 Mar 16;37(3):270-288. doi: 10.1016/j.ccell.2020.02.004.
7
Recent insight into the role of FBXW7 as a tumor suppressor.近期对 FBXW7 作为肿瘤抑制因子的作用的深入了解。
Semin Cancer Biol. 2020 Dec;67(Pt 2):1-15. doi: 10.1016/j.semcancer.2020.02.017. Epub 2020 Feb 27.
8
mA mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.METTL3 介导的 mA mRNA 甲基化直接促进 YAP 翻译,并通过调节 MALAT1-miR-1914-3p-YAP 轴增加 YAP 活性,从而诱导 NSCLC 耐药和转移。
J Hematol Oncol. 2019 Dec 9;12(1):135. doi: 10.1186/s13045-019-0830-6.
9
mA methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways.甲基化转移酶METTL3通过p38/ERK信号通路抑制结直肠癌的增殖和迁移。
Onco Targets Ther. 2019 Jun 4;12:4391-4402. doi: 10.2147/OTT.S201052. eCollection 2019.
10
METTL3 facilitates tumor progression via an mA-IGF2BP2-dependent mechanism in colorectal carcinoma.METTL3 通过 mA-IGF2BP2 依赖的机制促进结直肠癌的肿瘤进展。
Mol Cancer. 2019 Jun 24;18(1):112. doi: 10.1186/s12943-019-1038-7.